Media Coverage · July 25, 2014
Acticor Biotech on Biotech.info
Biotechinfo.fr, the biotechnology newsletter, interviewed Martine Jandrot-Perrus and Philippe Billiald about the promising development of Acticor’s product for ischemic stroke.
Read next in 'Media Coverage'
- ACT017 : un fragment d’anticorps dont l’ACTion antithrombotique est prometteuse !
- Novel antiplatelet could circumvent bleeding risk for stroke patients
- Experimental antiplatelet compound for acute stroke shows promise
- New drug to prevent clots clears safety hurdle
- New blood thinner may prevent stroke, without risk for bleeding